Logo image of SVS.MI

SVAS BIOSANA SPA (SVS.MI) Stock Price, Quote, News and Overview

BIT:SVS - Euronext Milan - IT0005469264 - Common Stock - Currency: EUR

7.82  0 (0%)

SVS.MI Quote, Performance and Key Statistics

SVAS BIOSANA SPA

BIT:SVS (5/21/2025, 7:00:00 PM)

7.82

0 (0%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies
Statistics
52 Week HighN/A
52 Week LowN/A
Market Cap43.79M
Shares5.60M
Float1.70M
Yearly DividendN/A
Dividend Yield3.2%
PE7.67
Fwd PE5.96
Earnings (Next)N/A N/A
IPO12-09 2021-12-09


SVS.MI short term performance overview.The bars show the price performance of SVS.MI in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 -10 -20 -30

SVS.MI long term performance overview.The bars show the price performance of SVS.MI in the last 1, 2 and 3 years. 1 year 2 years 3 years -2 -4 -6

The current stock price of SVS.MI is 7.82 EUR. In the past month the price increased by 10.92%.

SVAS BIOSANA SPA / SVS Daily stock chart

SVS.MI Competitors/Peers

The largest stocks on the EU markets in the "Health Care Supplies" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
EL.PA ESSILORLUXOTTICA 36.63 113.81B
1EL.MI ESSILORLUXOTTICA 36.51 113.42B
ESL.DE ESSILORLUXOTTICA 36.51 113.42B
2U3.DE ALCON INC 28.48 37.72B
CBHD.DE COLOPLAST-B 31.12 18.18B
GENT.OL GENTIAN DIAGNOSTICS ASA 20.21 900.53M
GBT.PA GUERBET 16.54 265.44M
ALCJ.PA CROSSJECT N/A 80.44M
PTP.DE PENTIXAPHARM HOLDING AG N/A 67.21M
AFME.PA AFFLUENT MEDICAL SA N/A 56.27M

About SVS.MI

Company Profile

SVS logo image Svas Biosana SpA engages in distributing medical appliances. The company is headquartered in Somma Vesuviana, Napoli. The company went IPO on 2021-12-09. The firm has two core businesses, namely industrial core and sales core. Industrial core focuses on production and marketing of medical devices, consisting of Farmex and Medical business lines. Sales core is dedicated to trading and distribution of medical devices, consisting of the SVAS and Mark Medical business lines. Farmex is focused on the production and sale of incontinence aids, traditional dressings, cotton wool and products for personal care. Medical business line focuses on production and sale of operating packs, medical devices for infusion and aspiration, linen, advanced dressings and lubricating gel for urology. SVAS is dedicated to selling specialist medical devices for medicine and surgery. Mark Medical is focused on selling medical devices. The firm operates globally.

Company Info

SVAS BIOSANA SPA

Via Trentola, 7

Somma Vesuviana NAPOLI IT

Employees: 327

SVS Company Website

SVS Investor Relations

Phone: 390818995411

SVAS BIOSANA SPA / SVS.MI FAQ

What is the stock price of SVAS BIOSANA SPA today?

The current stock price of SVS.MI is 7.82 EUR.


What is the ticker symbol for SVAS BIOSANA SPA stock?

The exchange symbol of SVAS BIOSANA SPA is SVS and it is listed on the Euronext Milan exchange.


On which exchange is SVS.MI stock listed?

SVS.MI stock is listed on the Euronext Milan exchange.


What is the price forecast or stock price prediction for SVAS BIOSANA SPA stock?

6 analysts have analysed SVS.MI and the average price target is 12.65 EUR. This implies a price increase of 61.74% is expected in the next year compared to the current price of 7.82. Check the SVAS BIOSANA SPA stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is SVAS BIOSANA SPA worth?

SVAS BIOSANA SPA (SVS.MI) has a market capitalization of 43.79M EUR. This makes SVS.MI a Nano Cap stock.


How many employees does SVAS BIOSANA SPA have?

SVAS BIOSANA SPA (SVS.MI) currently has 327 employees.


What are the support and resistance levels for SVAS BIOSANA SPA (SVS.MI) stock?

SVAS BIOSANA SPA (SVS.MI) has a support level at 7 and a resistance level at 8.26. Check the full technical report for a detailed analysis of SVS.MI support and resistance levels.


Is SVAS BIOSANA SPA (SVS.MI) expected to grow?

The Revenue of SVAS BIOSANA SPA (SVS.MI) is expected to grow by 5.8% in the next year. Check the estimates tab for more information on the SVS.MI EPS, Sales, EBIT and EBITDA future analyst estimates.


Should I buy SVAS BIOSANA SPA (SVS.MI) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does SVAS BIOSANA SPA (SVS.MI) stock pay dividends?

SVAS BIOSANA SPA (SVS.MI) has a dividend yield of 3.2%. The yearly dividend amount is currently 0. Check the full fundamental report for a detailed analysis of SVS.MI dividend history, reliability and sustainability.


What is the Price/Earnings (PE) ratio of SVAS BIOSANA SPA (SVS.MI)?

The PE ratio for SVAS BIOSANA SPA (SVS.MI) is 7.67. This is based on the reported non-GAAP earnings per share of 1.02 and the current share price of 7.82 EUR. Check the full fundamental report for a full analysis of the valuation metrics for SVS.MI.


SVS.MI Technical Analysis

ChartMill assigns a technical rating of 2 / 10 to SVS.MI.


Chartmill TA Rating
Chartmill Setup Rating

SVS.MI Fundamental Analysis

ChartMill assigns a fundamental rating of 6 / 10 to SVS.MI. SVS.MI has only an average score on both its financial health and profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SVS.MI Financial Highlights

Over the last trailing twelve months SVS.MI reported a non-GAAP Earnings per Share(EPS) of 1.02. The EPS increased by 32.52% compared to the year before.


Industry RankSector Rank
PM (TTM) 4.49%
ROA 3.44%
ROE 9.25%
Debt/Equity 0.64
Chartmill High Growth Momentum
EPS Q2Q%15.52%
Sales Q2Q%5.91%
EPS 1Y (TTM)32.52%
Revenue 1Y (TTM)12.19%

SVS.MI Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 80% to SVS.MI. The Buy consensus is the average rating of analysts ratings from 6 analysts.

For the next year, analysts expect an EPS growth of 20.69% and a revenue growth 5.8% for SVS.MI


Ownership
Inst Owners7.88%
Ins Owners64.79%
Short Float %N/A
Short RatioN/A
Analysts
Analysts80
Price Target12.65 (61.76%)
EPS Next Y20.69%
Revenue Next Year5.8%